Atlas FDA

Stelo Glucose Biosensor System

FDA 510(k) clearance K261359 · decided 2026-05-21

Clearance details

K-number
K261359
Device name
Stelo Glucose Biosensor System
Applicant
Dexcom, Inc.
Decision
Substantially Equivalent
Date received
2026-04-24
Decision date
2026-05-21
Days to decision
27 days
Clearance type
Special
Product code
SAF
Device class
2
Regulation number
862.1355
Medical specialty
Clinical Chemistry
Advisory committee
Clinical Chemistry
Location
San Diego, CA, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Dexcom

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
Signos Glucose Monitoring System (K250106)Signos, Inc.2025-03-21
Lingo Glucose System (K233655)Abbott2024-05-29
Stelo Glucose Biosensor System (K234070)Dexcom, Inc.2024-03-05

Recalls involving this device

No recalls on record reference this clearance.

PMA approvals by this applicant

RecordFirmDate
G5 Mobile Continuous Glucose Monitoring System, G6 Continuous Glucose Monitoring System, G7 Continuous Glucose Monitorin (P120005/S091)Dexcom, Inc.2024-01-09
DEXCOM G5 Mobile Continuous Glucose Monitoring System (P120005/S090)Dexcom, Inc.2023-01-12
Dexcom G5 Mobile Continuous Glucose Monitoring System (P120005/S088)Dexcom, Inc.2022-01-20
G5 Mobile Continuous Glucose Monitoring System (P120005/S089)Dexcom, Inc.2021-12-21
G5 Mobile Continuous Glucose Monitoring System (P120005/S087)Dexcom, Inc.2020-09-03
Dexcom G5 Mobile Continuous Glucose Monitoring System (P120005/S086)Dexcom, Inc.2020-01-08
DEXCOM G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM (P120005/S083)Dexcom, Inc.2019-11-01
Dexcom G4 PLATINUM Continuous Glucose Monitoring System, Dexcom G5 Mobile Continuous Glucose Monitoring System (P120005/S082)Dexcom, Inc.2019-08-20